Sign in
Not yet recruitingNo phase

Dietary Supplement for Myopia Control

Key facts

Who runs it
The Hong Kong Polytechnic University
Where
Hong Kong1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
156 people, planned
Started
1 Aug 2026
Expected to end
30 Dec 2026
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Oral dietary supplement provided in a capsule format (3 active capsules/ per day)
  • Oral dietary supplement provided in a capsule format (1 active capsule and 2 placebo capsules/per day)
  • Placebo control (3 placebo capsules/per day)
Record updated
24 July 2026

Who can take part

Age
8 years to 13 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Age 8-13 years
  • Cycloplegic spherical equivalent refraction (SER) of -0.50 D to -5.00 D with astigmatism of 2.5 D or less and best-corrected visual acuity (BCVA) of 0.0 logarithm or more in either eye
  • Anisometropia of 1.50 D or less
  • Intraocular pressure of 10 mmHg to 21 mmHg in both eyes
  • Willing to give written consent to participate in the study and accept random allocation in grouping

Who cannot take part

  • Receiving previous myopia control treatment including but not limited to atropine therapy and orthokeratology in the past 3 months
  • Ocular abnormalities leading to visual impairment
  • Severe physiological and psychological diseases affecting follow-up
  • Known history of allergy to any of the components of the dietary supplement or placebo, or history of an allergic reaction that required emergency treatment
  • Use of any other dietary supplements containing DHA/EPA, Lutein, or Astaxanthin in the past 3 months
  • Children who had other contraindications identified by the investigators that made them unsuitable for participation

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 8 and 13 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this clinical trial is to investigate the changes in choroidal thickness and vasculature in myopic children following oral supplementation.

The 3 groups in the trial

  • High concentration groupTreatment being tested

    3 active capsules/ per day

    Treatment: Oral dietary supplement provided in a capsule format (3 active capsules/ per day)

  • Low-concentration groupTreatment being tested

    1 active capsule and 2 placebo capsules/per day

    Treatment: Oral dietary supplement provided in a capsule format (1 active capsule and 2 placebo capsules/per day)

  • Control groupPlacebo, for comparison

    3 placebo capsules/per day

    Treatment: Placebo control (3 placebo capsules/per day)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effect of Dietary Supplements on Choroidal Thickness and Vasculature in Myopic Children: A Randomized, Double-Blind, Placebo-Controlled Trial
Criteria questions
Built from NCT07406906, who can take part
Record updated
24 July 2026